Fermín García-Muñoz Rodrigo
Research Subjects
Fermín García-Muñoz Rodrigo has a total of 139 co-authors. Here are the top co-authors by number of shared publications:
Lourdes Urquía Martí
Department of Neonatology, Hospital Universitario Materno-Infantil, Las Palmas de Gran Canaria, Spain
12 shared publications- Alejandro Avila-Alvarez
Neonatology Department, Complexo Hospitalario Universitario A Coruña (CHUAC), A Coruña, Spain
9 shared publications - Máximo Vento
Neonatal Research Group, Health Research Institute La Fe (IISLAFE), Valencia, Spain
8 shared publications Gloria Galán Henríquez
Department of Neonatology, Hospital Universitario Materno-Infantil, Las Palmas de Gran Canaria, Spain
7 shared publications- Josep Figueras-Aloy
Hospital Clínic, Catedràtic de Pediatria, Universitat de Barcelona, Barcelona, Spain
7 shared publications - Carlos Zozaya
Department of Neonatology, Hospital Universitario La Paz, Madrid, Spain
6 shared publications
Latest Publications
- 13 June 2026
- Published by Elsevier in Computers in Biology and Medicine
- Vol. 213, 111789
Predicting survival in extremely preterm infants: A multicenter machine learning study from Spain
- 13 June 2026
- Published by Elsevier in Computers in Biology and Medicine
- Vol. 213, 111789
Predicting survival in extremely preterm infants: A multicenter machine learning study from Spain
- 14 August 2025
- Published by Springer Nature in Pediatric Research
- Vol. 99 (1) , 375-378
Innovation, commitment, and humanity in brain-aware care: the legacy of Dr. Alfredo García-Alix in neonatal neurology
Neurological disorders acquired during the perinatal period are a leading cause of long-term childhood disability and constitute a significant portion of the global disease burden. Despite progress in reducing neonatal mortality, neurological morbidity remains a major challenge. Neonatal neurology, a relatively new subspecialty, aims to improve outcomes for affected infants through advances in understanding neurological injury mechanisms, developing assessment tools, and implementing preventive and therapeutic strategies. In Spain, neonatal neurology has significantly progressed over the past three decades, largely due to the contributions of Dr. Alfredo García-Alix. Recognized as a pioneer in the field, he played a crucial role in establishing neonatal neurological care services and fostering education and research. After training at Washington University in St. Louis, he introduced comprehensive neonatal neurology programs in Spain and co-founded the NeNe Foundation to advance education in the field. He also led the creation of the ‘Spanish Neonatal Brain Group’ and contributed extensively to neonatal neurology research. Dr. García-Alix was an advocate for holistic, multidisciplinary neonatal care, emphasizing early intervention, neuroprotective strategies, and parental involvement. His work significantly influenced neonatal care models in Spain and Latin America, and his legacy continues to shape the field through his teachings, research, and clinical contributions.
- 14 August 2025
- Published by Springer Nature in Pediatric Research
- Vol. 99 (1) , 375-378
Innovation, commitment, and humanity in brain-aware care: the legacy of Dr. Alfredo García-Alix in neonatal neurology
Neurological disorders acquired during the perinatal period are a leading cause of long-term childhood disability and constitute a significant portion of the global disease burden. Despite progress in reducing neonatal mortality, neurological morbidity remains a major challenge. Neonatal neurology, a relatively new subspecialty, aims to improve outcomes for affected infants through advances in understanding neurological injury mechanisms, developing assessment tools, and implementing preventive and therapeutic strategies. In Spain, neonatal neurology has significantly progressed over the past three decades, largely due to the contributions of Dr. Alfredo García-Alix. Recognized as a pioneer in the field, he played a crucial role in establishing neonatal neurological care services and fostering education and research. After training at Washington University in St. Louis, he introduced comprehensive neonatal neurology programs in Spain and co-founded the NeNe Foundation to advance education in the field. He also led the creation of the ‘Spanish Neonatal Brain Group’ and contributed extensively to neonatal neurology research. Dr. García-Alix was an advocate for holistic, multidisciplinary neonatal care, emphasizing early intervention, neuroprotective strategies, and parental involvement. His work significantly influenced neonatal care models in Spain and Latin America, and his legacy continues to shape the field through his teachings, research, and clinical contributions.
- Open Access
- 30 August 2024
- Published by Elsevier in Anales de Pediatría (English Edition)
- Vol. 101 (3) , 155-156
Presentation of studies at conferences and their final full publication in the field of neonatology in Spain
- 30 August 2024
- Published by Elsevier in Anales de Pediatría (English Edition)
- Vol. 101 (3) , 155-156
Open AccessPresentation of studies at conferences and their final full publication in the field of neonatology in Spain
- Open Access
- 2 July 2024
- Published by Elsevier in Jornal de Pediatria
- Vol. 100 (5) , 558
Corrigendum to
- 2 July 2024
- Published by Elsevier in Jornal de Pediatria
- Vol. 100 (5) , 558
Open AccessCorrigendum to
- Open Access
Lung Microbiota and Ventilator-Associated Pneumonia in the Neonatal Period
The lung microbiota is a complex community of microorganisms that colonize the respiratory tract of individuals from, or even before, birth. Although the lungs were traditionally believed to be sterile, recent research has shown that there is a diversity of bacterial species in the respiratory system. Knowledge about the lung microbiota in newborns and its relationship with bacterial infections is of vital importance to understand the pathogenesis of respiratory diseases in neonatal patients undergoing mechanical ventilation. In this article, the current evidence on the composition of the lung microbiota in newborns will be reviewed, as well as the risks that an altered microbiota can impose on premature newborns. Although advances in neonatal intensive care units have significantly improved the survival rate of preterm infants, the diagnosis and treatment of ventilator-associated pneumonia has not progressed in recent decades. Avoiding dysbiosis caused by inappropriate use of antibiotics around birth, as well as avoiding intubation of patients or promoting early removal of endotracheal tubes, are among the most important preventive measures for ventilator-associated pneumonia. The potential benefit of probiotics and prebiotics in preventing infectious, allergic or metabolic complications in the short or long term is not clearly established and constitutes a very important field of research in perinatal medicine.
Open AccessLung Microbiota and Ventilator-Associated Pneumonia in the Neonatal Period
The lung microbiota is a complex community of microorganisms that colonize the respiratory tract of individuals from, or even before, birth. Although the lungs were traditionally believed to be sterile, recent research has shown that there is a diversity of bacterial species in the respiratory system. Knowledge about the lung microbiota in newborns and its relationship with bacterial infections is of vital importance to understand the pathogenesis of respiratory diseases in neonatal patients undergoing mechanical ventilation. In this article, the current evidence on the composition of the lung microbiota in newborns will be reviewed, as well as the risks that an altered microbiota can impose on premature newborns. Although advances in neonatal intensive care units have significantly improved the survival rate of preterm infants, the diagnosis and treatment of ventilator-associated pneumonia has not progressed in recent decades. Avoiding dysbiosis caused by inappropriate use of antibiotics around birth, as well as avoiding intubation of patients or promoting early removal of endotracheal tubes, are among the most important preventive measures for ventilator-associated pneumonia. The potential benefit of probiotics and prebiotics in preventing infectious, allergic or metabolic complications in the short or long term is not clearly established and constitutes a very important field of research in perinatal medicine.
- Open Access
- 1 February 2024
- Published by MDPI AG in Preprints.org
Lung Microbiota and Ventilator‐Associated Pneumonia in the Neonatal Period
The lung microbiota is a complex community of microorganisms that colonize the respiratory tract of individuals from or even before birth. Although the lungs were traditionally believed to be sterile, recent research has shown that there is a diversity of bacterial species in the respiratory system. Knowledge about the lung microbiota in the newborn and its relationship with bacterial infections is of vital importance to understand the pathogenesis of respiratory diseases in neona-tal patients undergoing mechanical ventilation. In this article, the current evidence on the compo-sition of the lung microbiota in the newborn will be reviewed, as well as its role in the develop-ment of bacterial infections in mechanically ventilated neonates. Although advances in many as-pects of the neonatal intensive care unit care have significantly improved the survival of preterm infants, the diagnosis and treatment of ventilator-associated pneumonia has not progressed in recent decades. Avoiding dysbiosis caused by inappropriate use of antibiotics around birth, as well as avoiding intubation of patients or promoting early removal of endotracheal tubes are among the most important preventive measures for ventilator-associated pneumonia. The use of probiotics and prebiotics to prevent infectious, allergic or metabolic complications in the short or long term constitutes a very important field of research in perinatal medicine.
- 1 February 2024
- Published by MDPI AG in Preprints.org
Open AccessLung Microbiota and Ventilator‐Associated Pneumonia in the Neonatal Period
The lung microbiota is a complex community of microorganisms that colonize the respiratory tract of individuals from or even before birth. Although the lungs were traditionally believed to be sterile, recent research has shown that there is a diversity of bacterial species in the respiratory system. Knowledge about the lung microbiota in the newborn and its relationship with bacterial infections is of vital importance to understand the pathogenesis of respiratory diseases in neona-tal patients undergoing mechanical ventilation. In this article, the current evidence on the compo-sition of the lung microbiota in the newborn will be reviewed, as well as its role in the develop-ment of bacterial infections in mechanically ventilated neonates. Although advances in many as-pects of the neonatal intensive care unit care have significantly improved the survival of preterm infants, the diagnosis and treatment of ventilator-associated pneumonia has not progressed in recent decades. Avoiding dysbiosis caused by inappropriate use of antibiotics around birth, as well as avoiding intubation of patients or promoting early removal of endotracheal tubes are among the most important preventive measures for ventilator-associated pneumonia. The use of probiotics and prebiotics to prevent infectious, allergic or metabolic complications in the short or long term constitutes a very important field of research in perinatal medicine.
- Open Access
- 24 September 2023
- Published by Elsevier in Jornal de Pediatria
- Vol. 100 (1) , 100-107
Improved efficiency in the management of newborns with infectious risk factors by the sepsis risk calculator and clinical observation
- 24 September 2023
- Published by Elsevier in Jornal de Pediatria
- Vol. 100 (1) , 100-107
Open AccessImproved efficiency in the management of newborns with infectious risk factors by the sepsis risk calculator and clinical observation
- 24 August 2023
- Published by S. Karger AG in Neonatology
- Vol. 120 (6) , 718-726
Morbidity and Mortality of Very-Low-Birthweight Twin Infants according to Their Sex and the Sex of the Co-Twin: A Retrospective Cohort Study
Introduction: The concept of male disadvantage regarding the prognosis of premature newborns was introduced more than half a century ago, and it has been corroborated over time. However, the influence of the sex of one twin on the outcomes of the other has yielded contradictory results. Objective: The aim of the study was to determine if, in twin pregnancies of VLBW infants, the outcomes of one twin are modified by the sex of the co-twin. Methods: A multicentre retrospective study of a cohort of infants admitted to the collaborating units of the Spanish SEN1500 neonatal network was conducted. Liveborn VLBW twin infants, from 23+0 to 31+6 weeks of gestational age (GA), admitted from 2011 to 2020 were included. Outborn patients, infants with major congenital anomalies, and cases with only one twin admitted were excluded. The main outcomes were survival until first hospital discharge, survival without moderate or severe bronchopulmonary dysplasia (BPD), survival without major brain damage (MBD), and survival without major morbidity. Incidence rate ratios (IRR) and 95% confidence intervals (CI) were calculated. Results: 2,111 twin pairs were included. Male infants exhibited worse outcomes than females (IRR; 95% CI) regarding survival (0.96; 0.94, 0.98), survival without moderate or severe BPD (0.89; 0.86, 0.93), survival without MBD (0.94; 0.91, 0.97), and survival without major morbidity (0.87; 0.81, 0.93). Differences disappeared when the co-twin was a female infant: survival (1.00; 0.97, 1.03), survival without moderate or severe BPD (0.96; 0.91, 1.01), survival without MBD (0.99; 0.95, 1.04), and survival without major morbidity (0.94; 0.85, 1.03). Results for female infants did not change significantly with co-twin sex. Conclusions: Among VLBW twins from 23+0 to 31+6 weeks of GA, male infants have higher risk of morbidity and mortality overall. In cases of pregnancies with different-sex foetuses, males seem to improve their results, while these do not change for females. The underlying mechanism of this influence deserves further investigation.
- 24 August 2023
- Published by S. Karger AG in Neonatology
- Vol. 120 (6) , 718-726
Morbidity and Mortality of Very-Low-Birthweight Twin Infants according to Their Sex and the Sex of the Co-Twin: A Retrospective Cohort Study
Introduction: The concept of male disadvantage regarding the prognosis of premature newborns was introduced more than half a century ago, and it has been corroborated over time. However, the influence of the sex of one twin on the outcomes of the other has yielded contradictory results. Objective: The aim of the study was to determine if, in twin pregnancies of VLBW infants, the outcomes of one twin are modified by the sex of the co-twin. Methods: A multicentre retrospective study of a cohort of infants admitted to the collaborating units of the Spanish SEN1500 neonatal network was conducted. Liveborn VLBW twin infants, from 23+0 to 31+6 weeks of gestational age (GA), admitted from 2011 to 2020 were included. Outborn patients, infants with major congenital anomalies, and cases with only one twin admitted were excluded. The main outcomes were survival until first hospital discharge, survival without moderate or severe bronchopulmonary dysplasia (BPD), survival without major brain damage (MBD), and survival without major morbidity. Incidence rate ratios (IRR) and 95% confidence intervals (CI) were calculated. Results: 2,111 twin pairs were included. Male infants exhibited worse outcomes than females (IRR; 95% CI) regarding survival (0.96; 0.94, 0.98), survival without moderate or severe BPD (0.89; 0.86, 0.93), survival without MBD (0.94; 0.91, 0.97), and survival without major morbidity (0.87; 0.81, 0.93). Differences disappeared when the co-twin was a female infant: survival (1.00; 0.97, 1.03), survival without moderate or severe BPD (0.96; 0.91, 1.01), survival without MBD (0.99; 0.95, 1.04), and survival without major morbidity (0.94; 0.85, 1.03). Results for female infants did not change significantly with co-twin sex. Conclusions: Among VLBW twins from 23+0 to 31+6 weeks of GA, male infants have higher risk of morbidity and mortality overall. In cases of pregnancies with different-sex foetuses, males seem to improve their results, while these do not change for females. The underlying mechanism of this influence deserves further investigation.
- Open Access
Human Milk Feeding Is Associated with Decreased Incidence of Moderate-Severe Bronchopulmonary Dysplasia in Extremely Preterm Infants
Background: An increased rate of bronchopulmonary dysplasia (BPD) is reported in extremely preterm infants. A potential role of human milk feeding in protecting against this condition has been suggested. Methods: A retrospective descriptive study was conducted based on data about morbidity in the population of infants born between 22+0 and 26+6 weeks of gestation, included in the Spanish network SEN1500 during the period 2004–2019 and discharged alive. The primary outcome was moderate-severe BPD. Associated conditions were studied, including human milk feeding at discharge. The temporal trends of BPD and human milk feeding rates at discharge were also studied. Results: In the study population of 4341 infants, the rate of moderate-severe BPD was 43.7% and it increased to >50% in the last three years. The factors significantly associated with a higher risk of moderate-severe BPD were birth weight, male sex, high-frequency oscillatory ventilation, duration of invasive mechanical ventilation, inhaled nitric oxide, patent ductus arteriosus, and late-onset sepsis. Exclusive human milk feeding and any amount of human milk at discharge were associated with a lower incidence of moderate-severe BPD (OR 0.752, 95% CI 0.629–0.901 and OR 0.714, 95% CI 0.602–0.847, respectively). During the study period, the proportion of infants with moderate-severe BPD fed any amount of human milk at discharge increased more than twofold. And the proportion of infants with moderate-severe BPD who were exclusively fed human milk at discharge increased at the same rate. Conclusions: Our work shows an inverse relationship between human milk feeding at discharge from the neonatal unit and the occurrence of BPD.
Open AccessHuman Milk Feeding Is Associated with Decreased Incidence of Moderate-Severe Bronchopulmonary Dysplasia in Extremely Preterm Infants
Background: An increased rate of bronchopulmonary dysplasia (BPD) is reported in extremely preterm infants. A potential role of human milk feeding in protecting against this condition has been suggested. Methods: A retrospective descriptive study was conducted based on data about morbidity in the population of infants born between 22+0 and 26+6 weeks of gestation, included in the Spanish network SEN1500 during the period 2004–2019 and discharged alive. The primary outcome was moderate-severe BPD. Associated conditions were studied, including human milk feeding at discharge. The temporal trends of BPD and human milk feeding rates at discharge were also studied. Results: In the study population of 4341 infants, the rate of moderate-severe BPD was 43.7% and it increased to >50% in the last three years. The factors significantly associated with a higher risk of moderate-severe BPD were birth weight, male sex, high-frequency oscillatory ventilation, duration of invasive mechanical ventilation, inhaled nitric oxide, patent ductus arteriosus, and late-onset sepsis. Exclusive human milk feeding and any amount of human milk at discharge were associated with a lower incidence of moderate-severe BPD (OR 0.752, 95% CI 0.629–0.901 and OR 0.714, 95% CI 0.602–0.847, respectively). During the study period, the proportion of infants with moderate-severe BPD fed any amount of human milk at discharge increased more than twofold. And the proportion of infants with moderate-severe BPD who were exclusively fed human milk at discharge increased at the same rate. Conclusions: Our work shows an inverse relationship between human milk feeding at discharge from the neonatal unit and the occurrence of BPD.
- Open Access
- 25 May 2023
- Published by MDPI AG in Preprints.org
Human Milk Feeding Could Protect Extremely Preterm Infants from Bronchopulmonary Dysplasia
Introduction The increase in survival of extremely preterm infants has led to increased rates of bronchopulmonary dysplasia (BPD). Therefore, a potential role of human milk feeding in protecting against this condition has been suggested. Material and methods Retrospective descriptive study based on data about morbidity in the population of infants born from 22+0 to 26+6 weeks of gestation, included in the Spanish network SEN1500 during the period 2004-2019 and who were alive at discharge. The primary outcome was moderate-severe BPD. In addition, associated conditions were studied, including breastfeeding at discharge. The temporal trends of BPD and breastfeeding rates at discharge were also studied. Results In the study population of 4341 infants who survived to discharge, the rate of moderate-severe BPD was 43,7% and increased over the period to a rate >50% in the last three years. The factors significantly associated with a higher risk of moderate-severe BPD were male sex, high-frequency oscillatory ventilation, inhaled nitric oxide, patent ductus arteriosus, and late-onset sepsis. Exclusive human milk feeding at discharge and any amount of human milk at discharge were associated with a lower incidence of moderate-severe BPD (OR 0.752, 95% CI 0.629-0.901, and OR 0.714, 95% CI 0.602-0.847, respectively). The rates of human milk at discharge in infants with moderate-severe BPD increased over the period. In the last years, more than one-third of extremely preterm infants were discharged on exclusive human milk feeds, and about two-thirds of them on any amount of human milk feeding. Conclusions The results of the present study strongly support the role of any amount of human milk in preventing BDP in extremely preterm infants.
- 25 May 2023
- Published by MDPI AG in Preprints.org
Open AccessHuman Milk Feeding Could Protect Extremely Preterm Infants from Bronchopulmonary Dysplasia
Introduction The increase in survival of extremely preterm infants has led to increased rates of bronchopulmonary dysplasia (BPD). Therefore, a potential role of human milk feeding in protecting against this condition has been suggested. Material and methods Retrospective descriptive study based on data about morbidity in the population of infants born from 22+0 to 26+6 weeks of gestation, included in the Spanish network SEN1500 during the period 2004-2019 and who were alive at discharge. The primary outcome was moderate-severe BPD. In addition, associated conditions were studied, including breastfeeding at discharge. The temporal trends of BPD and breastfeeding rates at discharge were also studied. Results In the study population of 4341 infants who survived to discharge, the rate of moderate-severe BPD was 43,7% and increased over the period to a rate >50% in the last three years. The factors significantly associated with a higher risk of moderate-severe BPD were male sex, high-frequency oscillatory ventilation, inhaled nitric oxide, patent ductus arteriosus, and late-onset sepsis. Exclusive human milk feeding at discharge and any amount of human milk at discharge were associated with a lower incidence of moderate-severe BPD (OR 0.752, 95% CI 0.629-0.901, and OR 0.714, 95% CI 0.602-0.847, respectively). The rates of human milk at discharge in infants with moderate-severe BPD increased over the period. In the last years, more than one-third of extremely preterm infants were discharged on exclusive human milk feeds, and about two-thirds of them on any amount of human milk feeding. Conclusions The results of the present study strongly support the role of any amount of human milk in preventing BDP in extremely preterm infants.